Although dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and magnetic resonance spectroscopy (MRS) have great potential to provide routine assessment of cancer treatment response, their widespread application has been hampered by a lack of standards for use. Thus, the National Cancer Institute convened a workshop to assess developments and applications of these methods, develop s...

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a powerful protocol for assessing tumour progression from changes in tissue contrast enhancement. Manual colorectal tumour delineation is a challenging and time consuming task due to the complex enhancement patterns in the 4D sequence. There is a need for a consistent approach to colorectal tumour segmentation in DCE-MRI and we p...

Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) consists of the continuous acquisition of images before, during, and after the injection of a contrast agent. DCE-MRI allows for noninvasive evaluation of tumor parameters related to vascular perfusion and permeability and tissue volume fractions, and is frequently employed in both preclinical and clinical investigations. However, t...

Angiogenesis is a key step in the pathophysiology of tumor growth and metastatic spread. Recently, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has emerged as a method for assessing angiogenesis both during the initial diagnosis and for follow up of anti-angiogenic therapies. In this review, we discuss the technical aspects of implementing DCE-MRI in clinical practice with emp...

Dynamic contrast-enhanced MRI of the breast (DCE-MRI) is widely used for detection and quantification purposes of breast cancer. The particular acquisition procedure of DCE-MRI over time leads to motion artifacts which distort analysis results. In this work we examine two criteria for a segmentation approach to separate areas affected by motion artifacts from properly perfused regions. By appli...

PURPOSE To determine the optimal combination of parameters derived from 3T multiparametric (conventional magnetic resonance imaging [MRI], diffusion-weighted [DW] and dynamic contrast-enhanced [DCE]) MRI for differentiating malignant from benign orbital lymphoproliferative disorders (OLPDs). MATERIALS AND METHODS Forty patients with OLPDs (18 benign and 22 malignant) underwent conventional 3....

Tumor-related vessel length (TVE) was quantified as the number of pixels skeletonized tumor vessels on ultrafast dynamic contrast-enhanced MRI (UF-DCE MRI). The association between TVE and breast cancer subtypes investigated. Invasive presenting with human epidermal growth factor receptor 2 (HER2) associated increased tumor-related length.

BACKGROUND Dynamic contrast-enhanced (DCE) MR perfusion imaging allows assessment of vascular density and integrity of tumors. The purpose of this study was to determine the diagnostic efficacy of time intensity curve analysis on DCE MRI for characterization of head and neck tumors. METHODS Twenty patients underwent T1-weighted fast field echo DCE MRI with temporal resolution of 2.6 seconds. ...

Introduction: Dynamic contrast-enhanced (DCE-) MRI has become a valuable tool in the assessment of tumors and in the evaluation of the effects of treatment. Kinetic modeling with two or three (including tumor vascular component vp) compartments is commonly used to measure the parameter K, a first order rate constant that describes tumor perfusion and vascular permeability. In its calculation, t...

Although an MRI scanner is a single stand-alone modality, different acquisition techniques may be applied to collect structural and functional information, including vascular or angiogenic properties measured by dynamic contrast enhanced MRI (DCE-MRI) and Choline (Cho) metabolism measured by proton MR spectroscopy imaging (MRSI). They may provide complementary information for a better character...